Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for AC Immune (ACIU) over the last 4 years, with Q3 2019 value amounting to $0.93.

  • AC Immune's Shares Outstanding (Weighted Average) changed N/A to $0.93 in Q3 2019 from the same period last year, while for Sep 2019 it was $0.93, marking a year-over-year change of. This contributed to the annual value of $57.9 million for FY2017, which is 1549.24% up from last year.
  • Per AC Immune's latest filing, its Shares Outstanding (Weighted Average) stood at $0.93 for Q3 2019.
  • AC Immune's Shares Outstanding (Weighted Average)'s 5-year high stood at $57.9 million during Q4 2017, with a 5-year trough of $0.67 in Q2 2019.
  • Its 4-year average for Shares Outstanding (Weighted Average) is $21.7 million, with a median of $278272.3 in 2016.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 1419.81% in 2016, then skyrocketed by 1549.24% in 2017.
  • AC Immune's Shares Outstanding (Weighted Average) (Quarter) stood at $43.9 million in 2015, then increased by 14.2% to $50.1 million in 2016, then grew by 15.49% to $57.9 million in 2017, then tumbled by 100.0% to $0.93 in 2019.
  • Its Shares Outstanding (Weighted Average) was $0.93 in Q3 2019, compared to $0.67 in Q2 2019 and $0.94 in Q1 2019.